Salesforce raised to buy from underperform by BofA; price objective raised to $285 from $160
CRM•BofA Global Research raised its rating on Salesforce to buy from underperform and increased its price objective to $285 from $160.
CRM•CRM•CRM•BofA Global Research raised its rating on Salesforce to buy from underperform and increased its price objective to $285 from $160.
